Psychotomimetism: Difference between revisions
No edit summary Tags: Visual edit Mobile edit Mobile web edit |
Javelinhands (talk | contribs) There was a paragraph claiming 1. That PCP is a hallucinogen, which is incorrect and 2. That LSD produced "intense" and "long lasting" psychotic symptoms in users, which there is no evidence for and which likely originated with the myth that LSD is stored in the spine after use. Any hallucinogenic drug is contraindicated for individuals with psychotic disorders and who are at risk for developing them, but the drug class of hallucinogen does not properly fit the description for psychotomimetic. |
||
| Line 9: | Line 9: | ||
[[Stimulant|Psychostimulants]], such as [[cocaine]] and [[Substituted amphetamine|amphetamines]] are known to produce psychotic symptoms similar to paranoid [[schizophrenia]] and [[Bipolar disorder|manic-depressive psychosis]]. |
[[Stimulant|Psychostimulants]], such as [[cocaine]] and [[Substituted amphetamine|amphetamines]] are known to produce psychotic symptoms similar to paranoid [[schizophrenia]] and [[Bipolar disorder|manic-depressive psychosis]]. |
||
[[Cathinone|Synthetic cathinones]] such as [[Bath salts (drug)|bath salts]] as well as [[Dissociative|dissociatives]] drugs such as [[Phencyclidine|PCP]] also elicit psychotic behavior in its users which may result in medical intervention. |
|||
[[Hallucinogen|Hallucinogens]], such as [[Lysergic acid diethylamide|LSD]] and [[Phencyclidine|PCP]] can produce intense psychotomimetic effects that may last for days or cause permanent brain alterations.{{Citation needed|date=November 2021}} |
|||
Drugs and substances such as [[3-Quinuclidinyl benzilate|BZ]] (QNB) also fall into the class of psychotomimetics. |
Drugs and substances such as [[3-Quinuclidinyl benzilate|BZ]] (QNB) also fall into the class of psychotomimetics. |
||
Revision as of 23:39, 15 December 2021
A drug with psychotomimetic (also known as psychotogenic) actions mimics the symptoms of psychosis, including delusions and/or delirium, as opposed to only hallucinations. Psychotomimesis is the onset of psychotic symptoms following the administration of such a drug.
Some rarely used drugs of the opioid class have psychotomimetic effects. Particularly, mixed kappa receptor agonist mu receptor antagonist opioid analgesics can cause dose-related psychotomimesis.[1] This adverse effect, incidence 1–2%, limits their use. Pentazocine and butorphanol fall under this opioid class.[2]
There is evidence that cannabinoids are psychotomimetic,[3] especially delta-9-tetrahydrocannabinol (Δ9-THC). D'Souza et al. (2004) found that intravenous THC produced effects that resemble schizophrenia in both the positive symptoms (hallucinations, delusions, and disorganized thinking) and negative symptoms (avolition, asociality, apathy, alogia, and anhedonia).[4] Some types of cannabis may be more psychotomimetic than others, probably due to the action of cannabidiol (CBD), which inhibits P450 3A11's metabolic conversion of THC to 11-Hydroxy-THC, which is four times more psychoactive.[5]p. 39
Carl Sagan used the word "psychotomimetic" in his anonymous article "Mr.X"[6] to describe the effects of cannabis, writing that "I smile, or sometimes even laugh out loud at the pictures on the insides of my eyelids. In this sense, I suppose cannabis is psychotomimetic, but I find none of the panic or terror that accompanies some psychoses."
Psychostimulants, such as cocaine and amphetamines are known to produce psychotic symptoms similar to paranoid schizophrenia and manic-depressive psychosis.
Synthetic cathinones such as bath salts as well as dissociatives drugs such as PCP also elicit psychotic behavior in its users which may result in medical intervention.
Drugs and substances such as BZ (QNB) also fall into the class of psychotomimetics.
List of psychotomimetic drugs
Examples of psychotomimetic substances:
- Amphetamine
- Atropine
- Benztropine
- Benzydamine
- Bupropion
- Butorphanol
- Cathinone
- Cocaine
- Cyclazocine
- Dimethyltryptamine (DMT)
- Diphenhydramine (DPH)
- Inhalants
- Ketamine
- Levorphanol
- Lysergic acid diethylamide (LSD)
- MDMA
- Mephedrone
- Mescaline
- Methamphetamine
- Methorphan
- Methylphenidate
- Myristicin
- Pentazocine
- Phencyclidine (PCP)
- Psilocybin
- Quinuclidinyl benzilate (QNB)
- Scopolamine
- Synthetic cannabinoids
- Tetrahydrocannabinol (THC)
See also
- Amphetamines
- Anticolinergics
- Antidepressants
- Antihistamines
- Antipsychotics
- Anxiogenics
- Anxiolytics
- Cannabinoids
- Cathinones
- Deliriants
- Depressants
- Depressogens
- Designer drugs
- Dissociatives
- Hallucinogens
- Hypnotics
- Narcotics
- Opioids
- Phenidates
- Psychedelics
- Sedatives
- Stimulants
References
- ^ Pfeiffer (1986). "Psychotomimesis mediated by kappa opiate receptors". Science. 233 (4765): 774–776. Bibcode:1986Sci...233..774P. doi:10.1126/science.3016896. PMID 3016896.
- ^ Musacchio JM (1990). "The psychotomimetic effects of opiates and the sigma receptor". Neuropsychopharmacology. 3 (3): 191–200. PMID 2163646.
- ^ Sewell R. A.; Ranganathan M.; D'Souza D. C. (2009). "Cannabinoids and psychosis". International Review of Psychiatry. 21 (2): 152–162. doi:10.1080/09540260902782802. PMID 19367509.
- ^ D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). "The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis" (PDF). Neuropsychopharmacology. 29 (8): 1558–1572. doi:10.1038/sj.npp.1300496. PMID 15173844.
- ^ Brenneisen R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In: ElSohly MA (ed). Marijuana and the cannabinoids. Humana Press Inc: Totowa, New Jersey, 2007.
- ^ Sagan, Carl. "Mr. X". Marijuana-Uses.com. Retrieved November 8, 2012.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |